Key result
Recombinant rN and rH/Nh proteins yield neutralizing antibodies at slightly lower titers than native antigen.
Recombinant proteins rN and rH/Nh of the measles virus strain NovO/96 elicit neutralizing antibodies in mice, with titers slightly lower than the native antigen.
Answers are grounded in this paper and cite their sources.
Recombinant measles antigens merit further preclinical testing; leaves open human immunogenicity, safety, and efficacy trials.
Recombinant proteins rN (nucleocapsid) and rH/Nh (hemagglutinin) of the measles virus strain NovO/96 of genotype A were obtained. The immunobiological properties of the proteins were studied in the reaction with a panel of positive and negative sera. BALB/c mice were immunized with recombinant proteins and native antigen of the measles virus strain NovO/96 in order to obtain hyperimmune serum and its analysis using ELISA (enzyme-linked immunosorbent assay) and PRN (plaque reduction neutralization). The hyperimmune sera against recombinant proteins and native antigen of the measles virus strain NovO/96 were found to be highly active in ELISA. The antibodies against the proteins rN and rH/Nh were found to be capable of neutralizing the virus in titer 1 : 13.5 and 1 : 22.9, respectively. The neutralization titer of the antibodies generated against native antigen of the measles virus strain NovO/96 was 1 : 25.7.
No takes yet. Share an insight, caveat, or question.
Kulak et al. (2008) studied Measles. Recombinant proteins rN and rH/Nh vs. Native antigen was evaluated on Virus neutralization titer. Immunization with recombinant proteins rN and rH/Nh generated neutralizing antibodies with titers of 1:13.5 and 1:22.9, compared to 1:25.7 for the native antigen.
Synapse has enriched 10 related papers. Consider them for comparative context: